NIH-funded research R01 grant

Improving syphilis screening using a new testing method

Official title: Evaluation of a Treponema pallidum transcription mediated amplification assay for Syphilis Screening

Funded at University of Washington · NIH-11142569 · Data updated 2026-11-12

This study is testing a new way to quickly detect syphilis in men who have sex with men and transgender individuals, using different types of samples like blood and rectal swabs, to help find infections earlier than current tests do.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startJune 8, 2021
Project endMay 31, 2027
Funding year2025
Award (this year)$1,094,147
NIH project number4R01AI155442-05
Project IDNIH-11142569 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include men who have sex with men and transgender individuals who are at risk for syphilis infection.

Less likely to help

Patients who are not at risk for syphilis or those who have already been diagnosed and treated for the infection may not benefit from this research.

What this research studies

This research investigates a novel transcription mediated amplification (TMA) assay for detecting syphilis, particularly among men who have sex with men and transgender individuals. The study aims to identify syphilis infections earlier than traditional serological tests, which can take weeks to show positive results. By analyzing various specimen types, including blood and rectal samples, the research seeks to determine the most effective methods for early detection of the infection. This could lead to better management and treatment of syphilis in affected populations.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and treatment of syphilis, reducing transmission rates and improving health outcomes.

How similar studies have gone: Previous research has shown promise in using similar amplification techniques for other infections, suggesting potential for success in this novel application.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Golden, Matthew R — University of Washington
  • Study coordinator: Golden, Matthew R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.